Tech Company Financing Transactions
Elcelyx Therapeutics Funding Round
Elcelyx Therapeutics, based in San Diego, raised $3.4 million from Kleiner Perkins Caufield & Byers and Morgenthaler Ventures.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$3,366,000
Round
Undisclosed
Investors
Kleiner Perkins Caufield & Byers (Brook Byers)
Morgenthaler Ventures (Ralph Christofferson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11995 El Camino Real 305
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
40% of treated type 2 diabetes patients are not able to take metformin, the first-line and foundational therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alain Baron
Chief Financial Officer
Jay Sherwood
Chief Scientific Officer
Mark Fineman
VP - Regulatory Affairs
Thomas Bicsak
Browse more venture capital transactions:
Prev: 9/30/2013: Labcyte venture capital transaction
Next: 9/30/2013: ShareThis venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs